SPNE Stock Overview
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
SeaSpine Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.54 |
| 52 Week High | US$13.64 |
| 52 Week Low | US$5.48 |
| Beta | 1.3 |
| 1 Month Change | 34.56% |
| 3 Month Change | 73.14% |
| 1 Year Change | -24.59% |
| 3 Year Change | -36.57% |
| 5 Year Change | -6.65% |
| Change since IPO | -54.57% |
Recent News & Updates
Recent updates
SeaSpine Holdings (NASDAQ:SPNE) Has Debt But No Earnings; Should You Worry?
Sep 24
SeaSpine: Bottom Line Fundamentals Continue To Soften
Sep 22SeaSpine amends $30M credit facility
Jul 19SeaSpine: Lacks Equity Premium To Deliver Real Risk-Adjusted Return
Jul 08Is SeaSpine Holdings (NASDAQ:SPNE) Using Debt Sensibly?
Jun 07SeaSpine begins limited commercial launch of the waveform L 3d-printed interbody system
Jun 08It Looks Like The CEO Of SeaSpine Holdings Corporation (NASDAQ:SPNE) May Be Underpaid Compared To Peers
May 27SeaSpine EPS misses by $0.13, beats on revenue
May 03SeaSpine guides Q4 and FY2020 revenue below consensus
Jan 11SeaSpine Holdings: Waiting To See If It Can Straighten Up
Dec 22Did SeaSpine Holdings' (NASDAQ:SPNE) Share Price Deserve to Gain 61%?
Dec 07SeaSpine (SPNE) Investor Presentation - Slideshow
Nov 17SeaSpine EPS beats by $0.06, beats on revenue; updates Q4 revenue guidance
Nov 09Shareholder Returns
| SPNE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 14.3% | -2.9% | -3.2% |
| 1Y | -24.6% | -3.7% | 19.3% |
Return vs Industry: SPNE underperformed the US Medical Equipment industry which returned -17.9% over the past year.
Return vs Market: SPNE underperformed the US Market which returned -21.5% over the past year.
Price Volatility
| SPNE volatility | |
|---|---|
| SPNE Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SPNE's share price has been volatile over the past 3 months.
Volatility Over Time: SPNE's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 523 | Keith Valentine | www.seaspine.com |
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company’s orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures.
SeaSpine Holdings Corporation Fundamentals Summary
| SPNE fundamental statistics | |
|---|---|
| Market cap | US$360.18m |
| Earnings (TTM) | -US$64.84m |
| Revenue (TTM) | US$229.75m |
1.6x
P/S Ratio-5.6x
P/E RatioIs SPNE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SPNE income statement (TTM) | |
|---|---|
| Revenue | US$229.75m |
| Cost of Revenue | US$87.83m |
| Gross Profit | US$141.92m |
| Other Expenses | US$206.75m |
| Earnings | -US$64.84m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.72 |
| Gross Margin | 61.77% |
| Net Profit Margin | -28.22% |
| Debt/Equity Ratio | 9.4% |
How did SPNE perform over the long term?
See historical performance and comparison